About News News Subscribe Health Policy (-) Economics Facet Area of Focus - News Jay Shimshack Raymond C. Scheppach Sebastian Tello Trillo Adam Leive Sarah Turner Benjamin Castleman Benjamin Castleman David Leblang Isaac Mbiti Molly Lipscomb Noah Myung (-) Christopher J. Ruhm (-) James R. Detert Facet People - News Facet UVA Partner - News Research and Commentary Facet News Type - News Nov 09, 2022 Stop Quiet Quitters From Sabotaging Your Company Economics Speaking with Investor's Business Daily, Batten School professor Jim Detert offers tips for identifying “quiet quitters” who are no longer as engaged with their employer’s mission. Learn more Oct 11, 2022 Quiet quitting and the great resignation have a common cause – dissatisfied workers feel they can’t speak up in the workplace Economics James Detert, Professor of Business Administration and faculty affiliate of the Batten School, explains "organizational silence" in an article for The Conversation. Workers stand up against inappropriate behavior roughly one-third of the time. There are four common fears that keep people from speaking up. Learn more May 17, 2021 How to target opioid funding to states that need it most Health Policy Economics According to new research from Batten’s Christopher J. Ruhm, the federal government’s opioid grant funding structure favors the least populous states, which are not always the states with greatest need. In an op-ed for The Hill, Ruhm suggests several ways to improve the targeting of federal grants that aim to assist states with opioid problems. Read in The Hill May 03, 2021 Federal Opioid Grant Funding Favors Least Populous States, Not Those With the Greatest Need Economics Health Policy In a new paper published in the journal Health Affairs, Batten’s Christopher J. Ruhm and co-author Bradley A. Katcher find that the federal government’s opioid grant funding structure favors the least populous states, which are not always the states with greatest need. Learn more Apr 09, 2020 How Might the COVID-19 Recession Affect Your Health? An Economist Explains. Economics Health Policy Recessions may be good for overall physical health, but this one could be different. Batten professor Chris Ruhm presented an online talk Wednesday offering an economist’s view of the overall health effects of the COVID-19 recession. His talk was the school’s third installment of its expert chat series about COVID-19. Learn more Nov 21, 2019 New Research: Non-Opioid Drug Death Rates Are Also on the Rise Economics The number of Americans dying from drug overdoses has risen rapidly in the last decade, with opioids viewed as the primary culprit. However, recent research suggests that opioids are not the only drug involved. According to Batten professor of economics, Christopher J. Ruhm, half of the overdose deaths have involved polydrug use and deaths involving nonopioid drugs are rising almost as fast as those involving opioids. READ IN UVA TODAY Stay Up To Date with the Latest Batten News and Events Subscribe
Nov 09, 2022 Stop Quiet Quitters From Sabotaging Your Company Economics Speaking with Investor's Business Daily, Batten School professor Jim Detert offers tips for identifying “quiet quitters” who are no longer as engaged with their employer’s mission. Learn more
Oct 11, 2022 Quiet quitting and the great resignation have a common cause – dissatisfied workers feel they can’t speak up in the workplace Economics James Detert, Professor of Business Administration and faculty affiliate of the Batten School, explains "organizational silence" in an article for The Conversation. Workers stand up against inappropriate behavior roughly one-third of the time. There are four common fears that keep people from speaking up. Learn more
May 17, 2021 How to target opioid funding to states that need it most Health Policy Economics According to new research from Batten’s Christopher J. Ruhm, the federal government’s opioid grant funding structure favors the least populous states, which are not always the states with greatest need. In an op-ed for The Hill, Ruhm suggests several ways to improve the targeting of federal grants that aim to assist states with opioid problems. Read in The Hill
May 03, 2021 Federal Opioid Grant Funding Favors Least Populous States, Not Those With the Greatest Need Economics Health Policy In a new paper published in the journal Health Affairs, Batten’s Christopher J. Ruhm and co-author Bradley A. Katcher find that the federal government’s opioid grant funding structure favors the least populous states, which are not always the states with greatest need. Learn more
Apr 09, 2020 How Might the COVID-19 Recession Affect Your Health? An Economist Explains. Economics Health Policy Recessions may be good for overall physical health, but this one could be different. Batten professor Chris Ruhm presented an online talk Wednesday offering an economist’s view of the overall health effects of the COVID-19 recession. His talk was the school’s third installment of its expert chat series about COVID-19. Learn more
Nov 21, 2019 New Research: Non-Opioid Drug Death Rates Are Also on the Rise Economics The number of Americans dying from drug overdoses has risen rapidly in the last decade, with opioids viewed as the primary culprit. However, recent research suggests that opioids are not the only drug involved. According to Batten professor of economics, Christopher J. Ruhm, half of the overdose deaths have involved polydrug use and deaths involving nonopioid drugs are rising almost as fast as those involving opioids. READ IN UVA TODAY